PMV Pharmaceuticals (PMVP) Operating Leases (2021 - 2025)
PMV Pharmaceuticals' (PMVP) quarterly Operating Leases came in at $435000.0 in Q4 2025, down 48.09% YoY from $838000.0 in Q4 2024, and down 19.59% on a QoQ basis from $541000.0 in Q3 2025.
PMV Pharmaceuticals (PMVP) Operating Leases (2021 - 2025) Analysis & Trends
PMV Pharmaceuticals (PMVP) has 5 years of Operating Leases data on file, last reported at $435000.0 in Q4 2025.
- Quarterly Operating Leases fell 48.09% year-over-year to $435000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $435000.0 (down 48.09% YoY) and the FY2025 annual result came in at $435000.0, down 48.09% from the prior year.
- Operating Leases declined to $435000.0 in Q4 2025, from $541000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $13.4 million in Q4 2022 to a low of $302000.0 in Q1 2021.
- A 5-year average of $8.6 million and a median of $11.7 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases soared 3701.32% — and 2025, when it slumped 95.5%.
- Tracing PMVP's Operating Leases over 5 years: stood at $10.8 million in 2021, then advanced by 24.63% to $13.4 million in 2022, then dropped by 7.54% to $12.4 million in 2023, then plunged by 93.26% to $838000.0 in 2024, then sank by 48.09% to $435000.0 in 2025.
- The last three Operating Leases figures came in at $435000.0 (Q4 2025), $541000.0 (Q3 2025), and $643000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMV Pharmaceuticals | 70.74 Mn | -8.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 435,000.00 |
| Sep 30, 2025 | 541,000.00 |
| Jun 30, 2025 | 643,000.00 |
| Mar 31, 2025 | 742,000.00 |
| Dec 31, 2024 | 838,000.00 |
| Sep 30, 2024 | 12.02 Mn |
| Jun 30, 2024 | 11.84 Mn |
| Mar 31, 2024 | 12.14 Mn |
| Dec 31, 2023 | 12.43 Mn |
| Sep 30, 2023 | 12.70 Mn |
| Jun 30, 2023 | 12.96 Mn |
| Mar 31, 2023 | 13.20 Mn |
| Dec 31, 2022 | 13.45 Mn |
| Sep 30, 2022 | 12.14 Mn |
| Jun 30, 2022 | 12.21 Mn |
| Mar 31, 2022 | 11.48 Mn |
| Dec 31, 2021 | 10.79 Mn |
| Sep 30, 2021 | 10.67 Mn |
| Jun 30, 2021 | 10.56 Mn |
| Mar 31, 2021 | 302,000.00 |